BCHE and early-onset autosomal dominant Alzheimer disease: Currently, Alzheimer's disease therapy is not just based on the symptomatic effects of cholinesterase inhibitors but also addresses the theories of neurodegeneration of cholinergic neutrons in the brain [21].